unmet needs in hemophilia treatment
Published 7 months ago • 79 plays • Length 1:18Download video MP4
Download video MP3
Similar videos
-
1:46
unmet needs in hemophilia b: treating patients who develop inhibitors
-
1:36
unmet needs in hemophilia: guidelines for emicizumab & better therapeutics for hemophilia a
-
1:55
unmet needs in dlbcl: frontline therapy, car-t optimization, and clinical trial inclusion
-
0:51
unmet need in hemophilia a: breakthrough bleeds
-
1:17
the current standard of care in hemophilia and unmet needs in this space
-
2:49
insights into areas of unmet need among patients with hemophilia a
-
2:46
unmet needs and challenges that remain in treating patients with scd in ssa
-
3:34
treating patients with aml who are ineligible for intensive chemotherapy
-
1:33:25
genealogy workshop: are you getting the most from your dna? an introduction
-
1:27
the impact of emicizumab on the hemophilia treatment landscape
-
4:36
haemonetics
-
1:23
the present and future of hemophilia a treatment
-
2:08
an overview of ongoing clinical trials for the treatment of hemophilia
-
1:13
the unmet needs and future of cmml treatment
-
1:03
tackling the unmet needs in gvhd from prophylaxis to treatment
-
0:44
unmet needs in aml: tp53 mutations and maintenance therapy
-
1:05
unmet needs in gvhd & the promise of regenerative medicine
-
1:08
the current landscape of hemophilia treatment: an update from ash 2023
-
0:51
unmet needs in front-line therapy for patients with flt3-mutated aml
-
2:01
the key unmet needs in a post-allosct newly diagnosed myeloma setting
-
4:43
novel treatments being explored for patients with hemophilia: highlights from isth 2024